GlassScriptPhysician profile
Ahmed S Sufyan
NPI 1710148002
$15,952.11
in general payments reported to CMS, 2019-2025
38 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what 86% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,322 · 2020: $6,259 · 2021: $5,324 · 2022: $530 · 2023: $521 · 2024: $630 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,517.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,005.21 | 2019-2025 | Coblation |
| Acclarent, INC | $923.11 | 2019-2023 | Trudi Nav Cable, Acclarent Aera |
| Integra Lifesciences Corporation | $524.97 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Stryker Corporation | $419.24 | 2019-2025 | Medline Industries, INC., Scopis Ent, Core |
| Glaxosmithkline, LLC. | $398.09 | 2021-2025 | Nucala |
| Genzyme Corporation | $357.09 | 2019-2025 | |
| Medtronic, INC. | $309.55 | 2022-2025 | Stealthstation S8 Platform, Propel |
| Optinose US, INC. | $153.48 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $149.47 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $114.22 | 2023-2024 | Inspire |
| Kerecis Limited | $45.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Ars Pharmaceuticals Operations, INC. | $43.19 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $41.66 | 2019 | |
| Merck Sharp & Dohme LLC | $32.82 | 2025 | Keytruda |
| Neurent Medical Limited | $28.34 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $26.98 | 2022 | |
| Acera Surgical, INC. | $24.65 | 2025 | Restrata Wound Matrix |
| Convatec INC. | $24.13 | 2025 | |
| Hologic Sales and Service, LLC | $24.08 | 2023 | Coolseal Generator |
| Incyte Corporation | $21.63 | 2023 | Opzelura |
| Shire North American Group INC | $20.99 | 2019 | |
| Phadia US INC. | $19.66 | 2023 | Immunocap |
| Olympus America INC. | $18.55 | 2019 | |
| Cochlear Americas | $18.44 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Organogenesis INC. | $18.07 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.68 | 2025 | Xhance |
| Fortovia Therapeutics, INC. | $16.43 | 2019 | |
| Galderma Laboratories, L.P. | $15.74 | 2022 | |
| Xoran Technologies LLC | $15.71 | 2021 | |
| Genentech USA, INC. | $15.67 | 2020 | |
| Medtronic USA, INC. | $15.08 | 2019 | |
| Karl Storz Endoscopy-America | $14.46 | 2023 | Image 1 |
| Alk-Abello, INC | $13.84 | 2022 | |
| Leo Pharma INC. | $13.66 | 2021 | |
| Hikma Pharmaceuticals USA | $13.52 | 2023 | Ryaltris |
| Sun Pharmaceutical Industries INC. | $13.31 | 2022 | |
| Allergan, INC. | $13.15 | 2019 | |
| Lilly USA, LLC | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Sufyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.